Targeting metastatic breast cancer with ANG1005, a novel peptide-paclitaxel conjugate that crosses the blood-brain-barrier (BBB)
For more detail on mechanism of action, signaling pathways, and controlled experimental applications, researchers can review the peer-reviewed literature below: Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications: Storage, Handling & Stability Guidelines Use the applicable lot/source record for storage of unopened material
Accessed 26 Jan Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions
Description Product Overview AOD-9604 is supplied by D&L Peptides as a 5 mg lyophilised laboratory reference material
15-unit draw: 4.28 mL BAC water produces about 2.3 mg BPC-157/mL
These short chains of amino acidsessentially the building blocks of proteinsact as signaling molecules in the body, instructing cells to repair, regenerate, or optimize specific functions